Flutiform 125 µg - 5 µg Druckgasinhalation, Suspension 比利时 - 德文 - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

flutiform 125 µg - 5 µg druckgasinhalation, suspension

mundipharma - fluticasone propionate; formoterolfumarat-dihydrat - druckgasinhalation, suspension - 125 µg - 5 µg - fluticasone propionate 125 µg; formoterolfumarat-dihydrat 5 µg - formoterol and fluticasone

Flutiform 250 µg - 10 µg Druckgasinhalation, Suspension 比利时 - 德文 - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

flutiform 250 µg - 10 µg druckgasinhalation, suspension

mundipharma - fluticasone propionate; formoterolfumarat-dihydrat - druckgasinhalation, suspension - 250 µg - 10 µg - fluticasone propionate 0.25 mg; formoterolfumarat-dihydrat 0.01 mg - formoterol and fluticasone

Flutiform K-haler 125 µg/dose - 5 µg/dose Druckgasinhalation, Suspension 比利时 - 德文 - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

flutiform k-haler 125 µg/dose - 5 µg/dose druckgasinhalation, suspension

mundipharma - fluticasone propionate; formoterolfumarat-dihydrat - druckgasinhalation, suspension - 125 µg/dose - 5 µg/dose - fluticasone propionate 0.125 mg/dose; formoterolfumarat-dihydrat 0.005 mg/dosis - formoterol and fluticasone

Flutiform K-haler 50 µg/dose - 5 µg/dose Druckgasinhalation, Suspension 比利时 - 德文 - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

flutiform k-haler 50 µg/dose - 5 µg/dose druckgasinhalation, suspension

mundipharma - fluticasone propionate; formoterolfumarat-dihydrat - druckgasinhalation, suspension - 50 µg/dose - 5 µg/dose - fluticasone propionate 0.05 mg/dose; formoterolfumarat-dihydrat 0.005 mg/dosis - formoterol and fluticasone

Inuvair 200 µg/dose - 6 µg/dose Druckgasinhalation, Lösung 比利时 - 德文 - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

inuvair 200 µg/dose - 6 µg/dose druckgasinhalation, lösung

chiesi - beclometasone dipropionate; formoterolfumarat-dihydrat - druckgasinhalation, lösung - 200 µg/dose - 6 µg/dose - beclometasone dipropionate 200 µg/dose; formoterolfumarat-dihydrat 6 µg/dosis - formoterol and beclometasone

Inuvair Nexthaler 100 µg/dose - 6 µg/dose Pulver zur Inhalation 比利时 - 德文 - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

inuvair nexthaler 100 µg/dose - 6 µg/dose pulver zur inhalation

chiesi - beclometasone dipropionate; formoterolfumarat-dihydrat - pulver zur inhalation - 100 µg/dose - 6 µg/dose - beclometasone dipropionate 100 µg/dose; formoterolfumarat-dihydrat 6 µg/dosis - formoterol and beclometasone

Inuvair Nexthaler 200 µg/dose - 6 µg/dose Pulver zur Inhalation 比利时 - 德文 - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

inuvair nexthaler 200 µg/dose - 6 µg/dose pulver zur inhalation

chiesi - beclometasone dipropionate; formoterolfumarat-dihydrat - pulver zur inhalation - 200 µg/dose - 6 µg/dose - beclometasone dipropionate 200 µg/dose; formoterolfumarat-dihydrat 6 µg/dosis - formoterol and beclometasone

Symbicort 160 µg/dose - 4,5 µg/dose Druckgasinhalation, Suspension 比利时 - 德文 - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

symbicort 160 µg/dose - 4,5 µg/dose druckgasinhalation, suspension

astrazeneca - budesonid; formoterolfumarat-dihydrat - druckgasinhalation, suspension - 160 µg/dose - 4,5 µg/dose - budesonid 160 µg/dose; formoterolfumarat-dihydrat 4.5 µg/dosis - formoterol and budesonide

Inuvair Nexthaler 200 µg/dose - 12 µg/dose Pulver zur Inhalation 比利时 - 德文 - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

inuvair nexthaler 200 µg/dose - 12 µg/dose pulver zur inhalation

chiesi - beclometasone dipropionate; formoterolfumarat-dihydrat - pulver zur inhalation - 200 µg/dose - 12 µg/dose - beclometasone dipropionate 200 µg/dose; formoterolfumarat-dihydrat 12 µg/dosis - formoterol and beclometasone

Trimbow 欧盟 - 德文 - EMA (European Medicines Agency)

trimbow

chiesi farmaceutici s.p.a. - beclometasone dipropionate, formoterol fumarat dihydrat, glycopyrronium bromide - lungenerkrankung, chronisch obstruktiv - medikamente für obstruktive atemwegserkrankungen, - maintenance treatment of asthma, in adults not adequately controlled with a maintenance combination of a long-acting beta2-agonist and high dose of inhaled corticosteroid, and who experienced one or more asthma exacerbations in the previous year. copdmaintenance treatment in adult patients with moderate to severe chronic obstructive pulmonary disease (copd) who are not adequately treated by a combination of an inhaled corticosteroid and a long-acting beta2-agonist or a combination of a long-acting beta2-agonist and a long-acting muscarinic antagonist (for effects on symptoms control and prevention of exacerbations see section 5. asthmamaintenance treatment of asthma, in adults not adequately controlled with a maintenance combination of a long-acting beta2-agonist and medium dose of inhaled corticosteroid, and who experienced one or more asthma exacerbations in the previous year.